{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:27:01Z","timestamp":1780637221456,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["Dec. No. 2012\/07\/B\/NZ7\/04212"],"award-info":[{"award-number":["Dec. No. 2012\/07\/B\/NZ7\/04212"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s43440-022-00360-5","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T05:02:53Z","timestamp":1647406973000},"page":"759-768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Chemokine (C\u2013C motif) ligand 5 (RANTES) concentrations in the peripheral blood of patients with a depressive disorder"],"prefix":"10.1007","volume":"74","author":[{"given":"El\u017cbieta","family":"Ma\u0142uj\u0142o-Balcerska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kumor-Kisielewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Szemraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Pietras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"360_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/PSY.0000000000000678","volume":"81","author":"R Thom","year":"2019","unstructured":"Thom R, Silbersweig DA, Boland RJ. Major depressive disorder in medical illness: a review of assessment, prevalence, and treatment options. Psychosom Med. 2019;81:246\u201355.","journal-title":"Psychosom Med"},{"key":"360_CR2","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.3390\/jcm9123793","volume":"9","author":"A Nobis","year":"2020","unstructured":"Nobis A, Zalewski D, Waszkiewicz N. Peripheral markers of depression. J Clin Med. 2020;9:3793.","journal-title":"J Clin Med"},{"key":"360_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102504","volume":"19","author":"MC Petralia","year":"2020","unstructured":"Petralia MC, Mazzon E, Fagone P, Basile MS, Lenzo V, Quattropani MC, et al. The cytokine network in the pathogenesis of major depressive disorder. Close to translation? Autoimmun Rev. 2020;19: 102504.","journal-title":"Autoimmun Rev"},{"key":"360_CR4","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1172\/JCI44678","volume":"121","author":"SM Wajner","year":"2011","unstructured":"Wajner SM, Goemann IM, Bueno AL, Larsen PR, Maia AL. IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. J Clin Invest. 2011;121:1834\u201345.","journal-title":"J Clin Invest"},{"key":"360_CR5","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s43440-021-00280-w","volume":"73","author":"K Curzytek","year":"2021","unstructured":"Curzytek K, Le\u015bkiewicz M. Targeting the CCL2-CCR2 axis in depressive disorders. Pharmacol Rep. 2021;73:1052\u201362.","journal-title":"Pharmacol Rep"},{"key":"360_CR6","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s43440-021-00269-5","volume":"73","author":"K Chamera","year":"2021","unstructured":"Chamera K, Szuster-G\u0142uszczak M, Basta-Kaim A. Shedding light on the role of CX3CR1 in the pathogenesis of schizophrenia. Pharmacol Rep. 2021;73:1063\u201378.","journal-title":"Pharmacol Rep"},{"key":"360_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/mp.2017.205","volume":"23","author":"SP Leighton","year":"2018","unstructured":"Leighton SP, Nerurkar L, Krishnadas R, Johnman GJ. Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Mol Psychiatry. 2018;23:48\u201358.","journal-title":"Mol Psychiatry"},{"key":"360_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbi.2020.05.047","volume":"87","author":"Danilo Arnone Chemokines","year":"2020","unstructured":"Danilo Arnone Chemokines. a novel target for personalised treatment in major depressive disorders. Brain Behav Immun. 2020;87:205\u20136.","journal-title":"Brain Behav Immun"},{"key":"360_CR9","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1517\/14728222.2013.837886","volume":"17","author":"RE Marques","year":"2013","unstructured":"Marques RE, Guabiraba R, Russo RC, Teixeira MM. Targeting CCL5 in inflammation. Expert Opin Ther Targets. 2013;17:1439\u201360.","journal-title":"Expert Opin Ther Targets"},{"key":"360_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2017.09.013","volume":"122","author":"C Bakogiannis","year":"2019","unstructured":"Bakogiannis C, Sachse M, Stamatelopoulos K, Stellos K. Platelet-derived chemokines in inflammation and atherosclerosis. Cytokine. 2019;122: 154157.","journal-title":"Cytokine"},{"key":"360_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L","volume":"43","author":"PC Taylor","year":"2000","unstructured":"Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, McCloskey R, et al. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum. 2000;43:38\u201347.","journal-title":"Arthritis Rheum"},{"key":"360_CR12","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B","volume":"42","author":"M Leech","year":"1999","unstructured":"Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum. 1999;42:1601\u20138.","journal-title":"Arthritis Rheum"},{"key":"360_CR13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1189\/jlb.72.4.735","volume":"72","author":"G Losana","year":"2002","unstructured":"Losana G, Bovolenta Ch, Rigamonti L, Borghi I, Altare F, Jouanguy E, et al. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes. J Leukoc Biol. 2002;72:735\u201342.","journal-title":"J Leukoc Biol"},{"key":"360_CR14","first-page":"109","volume":"18","author":"S Patten","year":"1997","unstructured":"Patten S. Performance of the Composite International Diagnostic Interview Short Form for major depression in community and clinical samples. Chronic Dis Can. 1997;18:109\u201312.","journal-title":"Chronic Dis Can"},{"key":"360_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"360_CR16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.pharep.2016.04.019","volume":"68","author":"E Ga\u0142ecka","year":"2016","unstructured":"Ga\u0142ecka E, Talarowska M, Maes M, Su KP, G\u00f3rski P. Szemraj J Polymorphisms of iodothyronine deiodinases (DIO1, DIO3) genes are not associated with recurrent depressive disorder. Pharmacol Rep. 2016;68:913\u20137.","journal-title":"Pharmacol Rep"},{"key":"360_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.21307\/ane-2017-056","volume":"77","author":"E Ga\u0142ecka","year":"2017","unstructured":"Ga\u0142ecka E, Kumor-Kisielewska A, Orzechowska A, Maes M, G\u00f3rski P, Szemraj J. Assessment of type 1 and type 3 deiodinase expression levels in depressive disorders. Acta Neurobiol Exp (Wars). 2017;77:225\u201335.","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"360_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.advms.2019.04.001","volume":"64","author":"E Ga\u0142ecka","year":"2019","unstructured":"Ga\u0142ecka E, Kumor-Kisielewska A, G\u00f3rski P. Assessment of serum levels of DIO1 and DIO3 in patients diagnosed with COPD. Adv Med Sci. 2019;64:344\u20138.","journal-title":"Adv Med Sci"},{"key":"360_CR19","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-1171","author":"Ch Wenzek","year":"2022","unstructured":"Wenzek Ch, Boelen A, Westendorf AM, Enge DR, Lars C, Moeller LC, F\u00fchrer D. The interplay of thyroid hormones and the immune system - where we stand and why we need to know about it. Eur J Endocrinol. 2022. https:\/\/doi.org\/10.1530\/EJE-21-1171.","journal-title":"Eur J Endocrinol"},{"key":"360_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tem.2021.01.003","volume":"32","author":"PhW Gold","year":"2021","unstructured":"Gold PhW. Endocrine Factors in Key Structural and Intracellular Changes in Depression. Trends Endocrinol Metab. 2021;32:212\u201323.","journal-title":"Trends Endocrinol Metab"},{"key":"360_CR21","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1007\/s40618-021-01600-w","volume":"44","author":"M Bauer","year":"2021","unstructured":"Bauer M, Whybrow PC. Role of thyroid hormone therapy in depressive disorders. J Endocrinol Invest. 2021;44:2341\u20137.","journal-title":"J Endocrinol Invest"},{"key":"360_CR22","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666210922160116","author":"D Marazziti","year":"2021","unstructured":"Marazziti D, Torrigiani S, Carbone MG, Mucci F, Flamini W, Ivaldi T, Osso LD. Neutrophil\/lymphocyte, platelet\/lymphocyte and monocyte\/lymphocyte ratios in mood disorders. Curr Med Chem. 2021. https:\/\/doi.org\/10.2174\/0929867328666210922160116.","journal-title":"Curr Med Chem"},{"key":"360_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.chest.2019.08.2192","volume":"157","author":"O Kalchiem-Dekel","year":"2020","unstructured":"Kalchiem-Dekel O, Yao X, Levine SJ. Meeting the challenge of identifying new treatments for type 2-low neutrophilic asthma. Chest. 2020;157:26\u201333.","journal-title":"Chest"},{"key":"360_CR24","doi-asserted-by":"publisher","first-page":"bqaa200","DOI":"10.1210\/endocr\/bqaa200","volume":"162","author":"AH van der Spek","year":"2021","unstructured":"van an der Spek AH, Fliers E, Boelen A. Thyroid hormone and deiodination in innate immune cells. Endocrinology. 2021;162:bqaa200.","journal-title":"Endocrinology"},{"key":"360_CR25","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3390\/brainsci11111514","volume":"11","author":"Y Kong","year":"2021","unstructured":"Kong Y, He G, Zhang X. Li the role of neutrophil extracellular traps in lipopolysaccharide-induced depression-like behaviors in mice. Brain Sci. 2021;11:1514.","journal-title":"Brain Sci"},{"key":"360_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pharep.2014.08.006","volume":"67","author":"EA Og\u0142odek","year":"2015","unstructured":"Og\u0142odek EA, Szota AM, Just MJ, Mo\u015b DM, Araszkiewicz A. The MCP-1, CCL-5 and SDF-1 chemokines as pro-inflammatory markers in generalized anxiety disorder and personality disorders. Pharmacol Rep. 2015;67:85\u20139.","journal-title":"Pharmacol Rep"},{"key":"360_CR27","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.pharep.2015.05.023","volume":"67","author":"EA Og\u0142odek","year":"2015","unstructured":"Og\u0142odek EA, Szota AM, Mo\u015b DM, Araszkiewicz A, Szromek AR. Serum concentrations of chemokines (CCL-5 and CXCL-12), chemokine receptors (CCR-5 and CXCR-4), and IL-6 in patients with posttraumatic stress disorder and avoidant personality disorder. Pharmacol Rep. 2015;67:1251\u20138.","journal-title":"Pharmacol Rep"},{"key":"360_CR28","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.pharep.2014.06.001","volume":"66","author":"EA Og\u0142odek","year":"2014","unstructured":"Og\u0142odek EA, Szota A, Just MJ, Mo\u015b D, Araszkiewicz A. Comparison of chemokines (CCL-5 and SDF-1), chemokine receptors (CCR-5 and CXCR-4) and IL-6 levels in patients with different severities of depression. Pharmacol Rep. 2014;66:920\u20136.","journal-title":"Pharmacol Rep"},{"key":"360_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2017.05.012","volume":"94","author":"B Gadad","year":"2017","unstructured":"Gadad B, Jha M, Grannemann B, Mayes T, Trivedi M. Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: findings from the CO-MED trial. Randomized Controlled Trial. J Psychiatr Res. 2017;94:1\u20136.","journal-title":"J Psychiatr Res"},{"key":"360_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1590\/S1516-44462012000100013","volume":"34","author":"R Grassi-Oliveira","year":"2012","unstructured":"Grassi-Oliveira R, Brieztke E, Teixeira A, Pezzi JC, Zanini M, Lopes RP, et al. Peripheral chemokine levels in women with recurrent major depression with suicidal ideation. Braz J Psychiatry. 2012;34:71\u20135.","journal-title":"Braz J Psychiatry"},{"key":"360_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000513093","volume":"27","author":"O Bauer","year":"2020","unstructured":"Bauer O, Milenkovic VM, Hilbert S, Sarubin N, Weigl J, Bahr LM, Wetter TC, Heckel B, Wetzel CH, Rupprecht R, Nothdurfter C. Association of Chemokine (C\u2013C Motif) Receptor 5 and Ligand 5 with recovery from major depressive disorder and related neurocognitive impairment. NeuroImmunoModulation. 2020;27:152\u201362.","journal-title":"NeuroImmunoModulation"},{"key":"360_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neubiorev.2014.02.001","volume":"42","author":"MJ Stuart","year":"2014","unstructured":"Stuart MJ, Baune BT. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies. Neurosci Biobehav Rev. 2014;42:93\u2013115.","journal-title":"Neurosci Biobehav Rev"},{"key":"360_CR33","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.3390\/ijms22115495","volume":"22","author":"FB Almeida","year":"2021","unstructured":"Almeida FB, Pinna G, Tannhauser Barros HM. The role of HPA axis and allopregnanolone on the neurobiology of major depressive disorders and PTSD. Int J Mol Sci. 2021;22:5495.","journal-title":"Int J Mol Sci"},{"key":"360_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13104-017-2459-2","volume":"10","author":"V Albert","year":"2017","unstructured":"Albert V, Subramanian A, Agrawal D, Bhoi SK, Pallavi P, Mukhopadhayay AK. RANTES levels in peripheral blood, CSF and contused brain tissue as a marker for outcome in traumatic brain injury (TBI) patients. BMC Res. 2017;10:139.","journal-title":"BMC Res Notes."},{"key":"360_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ajp.2018.08.017","volume":"37","author":"MFI Leong Bin Abdullah","year":"2018","unstructured":"Leong Bin Abdullah MFI, Ng YP, Sidi HB. Depression and anxiety among traumatic brain injury patients in Malaysia. Asian J Psychiatr. 2018;37:67\u201370.","journal-title":"Asian J Psychiatr"},{"key":"360_CR36","volume":"2014","author":"P Tang","year":"2014","unstructured":"Tang P, Chong L, Li X, Liu Y, Liu P, Hou C, et al. Correlation between serum RANTES levels and the severity of Parkinson\u2019s disease. Oxid Med Cell Longev. 2014;2014: 208408.","journal-title":"Oxid Med Cell Longev"},{"key":"360_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000512657","volume":"6","author":"AA Tran","year":"2021","unstructured":"Tran AA, De Smet M, Grant GD, Khoo TK, Pountney DL. Investigating the convergent mechanism between major depressive disorder and parkinson\u2019s disease. Complex Psychiatry. 2021;6:47\u201361.","journal-title":"Complex Psychiatry"},{"key":"360_CR38","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1161\/01.CIR.103.13.1772","volume":"103","author":"P von Hundelshausen","year":"2001","unstructured":"von Hundelshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K, Weber C. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation. 2001;103:1772\u20137.","journal-title":"Circulation"},{"key":"360_CR39","first-page":"3026453","volume":"2019","author":"OM Koper-Lenkiewic","year":"2019","unstructured":"Koper-Lenkiewic OM, Kami\u0144ska J, Lisowska A, Milewska A, Hirnle T, Dymicka-Piekarska V. Factors associated with RANTES concentration in cardiovascular disease patients. BioMed Res Int. 2019;2019:3026453.","journal-title":"Biomed Res Int."},{"key":"360_CR40","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1089\/thy.2008.0261","volume":"19","author":"GA de Carvalho","year":"2009","unstructured":"de Carvalho GA, Bahls SC, Boeving A, Graf H. Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function. Thyroid. 2009;19:691\u20137.","journal-title":"Thyroid"},{"key":"360_CR41","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3390\/jcm10081706","volume":"10","author":"A Mosio\u0142ek","year":"2021","unstructured":"Mosio\u0142ek A, Pi\u0119ta A, Jakima S, Zborowska N, Mosio\u0142ek J, Szulc A. Effects of antidepressant treatment on peripheral biomarkers in patients with major depressive disorder (MDD). J Clin Med. 2021;10:1706.","journal-title":"J Clin Med"},{"key":"360_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2190\/PM.40.1.i","volume":"40","author":"H Chang-Quan","year":"2010","unstructured":"Chang-Quan H, Zheng-Rong W, Yong-Hong Li, Yi-Zhou X. Education and risk for late life depression: a meta-analysis of published literature. Int J Psychiatry Med. 2010;40:109\u201324.","journal-title":"Int J Psychiatry Med"},{"key":"360_CR43","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.ypmed.2014.11.003","volume":"76","author":"JA Bell\u00f3n","year":"2015","unstructured":"Bell\u00f3n JA, Moreno-Peral P, Emma Motrico E, Rodr\u00edguez-Morej\u00f3n A, Fern\u00e1ndez A, Serrano-Blanco A, et al. Effectiveness of psychological and\/or educational interventions to prevent the onset of episodes of depression: a systematic review of systematic reviews and meta-analyses. Prev Med. 2015;76:S22\u201332.","journal-title":"Prev Med"},{"key":"360_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/medicina57010011","volume":"57","author":"G Sampogna","year":"2020","unstructured":"Sampogna G, Lovisi GM, Zinno F, Del Vecchio V, Luciano M, et al. Mental health disturbances and related problems in Italian University medical students from 2000 to 2020: an integrative review of qualitative and quantitative studies. Medicina (Kaunas). 2020;57:11.","journal-title":"Medicina (Kaunas)"},{"key":"360_CR45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/JOM.0000000000002127","volume":"63","author":"MS Thiese","year":"2021","unstructured":"Thiese MS, Allen JA, Knudson M, Free K, Petersen P. Depressive symptoms and suicidal ideation among lawyers and other law professionals. J Occup Environ Med. 2021;63:381\u20136.","journal-title":"J Occup Environ Med"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-022-00360-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-022-00360-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-022-00360-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T07:12:52Z","timestamp":1674976372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-022-00360-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1007\/s43440-022-00360-5","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial interest related to the work described.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}